intoDNA

Private

PolandHealthcare & Life Scienceshttps://intodna.com/

Last Round

Angel

Jan 12, 2026

Total Funding Raised

$1.74M

Company Overview

intoDNA is a biotechnology company that provides DNA damage detection services and diagnostic insights for pharmaceutical and clinical research using its proprietary STRIDE platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

DNA damageDNA repairprecision medicinebiomarker discoverydrug discoveryhomologous recombination deficiencyHRDDNA damage responseDDRcompanion diagnosticCDxdigital pathologyassay developmentoncology researchbiotech CROsingle-cell analysislab services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

intoDNA Comps

Public and private peers based on sector, stage, and business model.

intoDNA comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

intoDNA Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Angel	Jan 12, 2026
Grant	Dec 9, 2024
Grant	Dec 20, 2021

View all Funding Rounds

intoDNA Investors

Notable investors and investment history

intoDNA investors
Investor	Rounds
SMOK Angels	Angel
SMOK Ventures	Angel
Polish Agency for Enterprise Development	Grant

View all Investors

intoDNA Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

intoDNA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about intoDNA's valuation, stock price, and market status.

Firmographic Details

HeadquartersPoland

Employee Range48

Year Founded2017

Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.